xu 62-320 and Malaria, Falciparum

xu 62-320 has been researched along with Malaria, Falciparum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baret, E; Briolant, S; Fontaine, A; Fusai, T; Henry, M; Mosnier, J; Pradines, B; Rogier, C; Torrentino-Madamet, M	1

Other Studies

1 other study(ies) available for xu 62-320 and Malaria, Falciparum

Article	Year
Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Animals; Antimalarials; Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrroles; Structure-Activity Relationship	2007

Article

Year

Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.

Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

Topics: Animals; Antimalarials; Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Inhibitory Concentration 50; Malaria, Falciparum; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrroles; Structure-Activity Relationship

2007